Literature DB >> 19139900

[Biocompatibility of dyes for vitreoretinal surgery].

S Thaler1, F Schüttauf, C Haritoglou.   

Abstract

For the last 8 years vital dyes have been used to visualize preretinal semitransparent structures in the eye during vitroretinal surgery. However, indocyanine green (ICG), which was the first commonly used dye, proved to be partly toxic to retinal cells and the retinal pigment epithelium in various in vitro and in vivo studies. Therefore, an intensive search for new and safer dyes was started. At present three dyes, trypan blue, patent blue and brilliant blue are predominantly used for vitreoretinal surgery, in addition to ICG. In this article an overview of preclinical biocompatibility studies for common vital dyes is presented. Additionally, a systematic approach for testing of new candidate dyes for vitreoretinal surgery will be proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139900     DOI: 10.1007/s00347-008-1854-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  32 in total

Review 1.  Vital staining and retinal detachment surgery.

Authors:  Timothy L Jackson
Journal:  Dev Ophthalmol       Date:  2008

2.  Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium.

Authors:  L Kodjikian; T Richter; M Halberstadt; F Beby; F Flueckiger; M Boehnke; J G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

3.  [Histological proof of indocyanine green angiography--healthy eyes].

Authors:  T Matsubara; M Uyama; I Fukushima; H Matsunaga; K Takahashi
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1999-07

4.  Staining and peeling of the internal limiting membrane using a fluorescent dye (Rhodamine 6 G).

Authors:  C Haritoglou; T Kreutzer; R Tadayoni; H Langhals; C A May; S Thaler; A Kampik
Journal:  Br J Ophthalmol       Date:  2008-06-27       Impact factor: 4.638

5.  Intracellular events in retinal glial cells exposed to ICG and BBG.

Authors:  Shuhei Kawahara; Yasuaki Hata; Muneki Miura; Takeshi Kita; Akihito Sengoku; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Akifumi Ueno; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

Review 6.  Safety parameters for indocyanine green in vitreoretinal surgery.

Authors:  Salvatore Grisanti; Andreas Altvater; Swaantje Peters
Journal:  Dev Ophthalmol       Date:  2008

7.  Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole.

Authors:  Marcin P Czajka; Brooks W McCuen; Thomas J Cummings; Hoang Nguyen; Sandra Stinnett; Fulton Wong
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

8.  In vivo toxicity study of rhodamine 6G in the rat retina.

Authors:  Sebastian Thaler; Christos Haritoglou; Tomasz J Choragiewicz; Andre Messias; Aneta Baryluk; C Albrecht May; Robert Rejdak; Michal Fiedorowicz; Eberhart Zrenner; Frank Schuettauf
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

9.  Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits.

Authors:  Fernando M Penha; Maurício Maia; Michel E Farah; Eduardo Dib; André H Príncipe; Fracois Devin; Eduardo B Rodrigues; João P Duprat; Edna Freymüller
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

10.  An in vivo evaluation of Brilliant Blue G in animals and humans.

Authors:  M Remy; S Thaler; R G Schumann; C A May; M Fiedorowicz; F Schuettauf; M Grüterich; S G Priglinger; M M Nentwich; A Kampik; C Haritoglou
Journal:  Br J Ophthalmol       Date:  2008-08       Impact factor: 4.638

View more
  1 in total

1.  Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina.

Authors:  Sebastian Mueller; Carlo Krupp; Sven Schnichels; Johanna Hofmann; Martin Spitzer; Karl Ulrich Bartz-Schmidt; Peter Szurman; Kai Januschowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-20       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.